Consilium Scientific
Patients deserve better clinical research. At Consilium Scientific, we are an independent non-profit committed to reforming clinical trials through scientific rigour, transparency, and accountability. We tackle the biggest challenges in healthcare and life sciences: waste in research, poor methodology, and skewed incentives.
Our seminars bring together leading scientists, policymakers, patient advocates, and educators to expose flaws, share solutions, and drive reform in medicine and health policy.
Expect live seminars every other Thursday on clinical trial transparency, drug development, medical ethics, health economics, and evidence-based policy reform, all broken down so the global healthcare community can understand the issues shaping patient care.
Subscribe to uncover the truth behind clinical research and join the movement for change.
Follow us on:
X: @consiliumsci
LinkedIn: https://www.linkedin.com/company/consilium-scientific/
Instagram: @consilium.scientific
Mark Sheehan - The Specialness of Rarity
Jonathan Kimmelman - Phase 2 Trials: The Forgotten Middle Child of Research Ethics
Reshma Ramachandran - Changing Goalposts: Evaluation of Novel Endpoints for Drug Approval
Nick DeVito - Examining Reproducibility in European Science
FDA Approved – And Ineffective
Ultra Rare, Ultra Challenging: A Multi-Stakeholder Dialogue on N-of-1 and Micro-rare Diseases
Do New Medicines Improve Population Health? Insights from NICE (2000–2020)
Jo Waller - The role of behavioural science in eliminating cervical cancer
Lawrence Lynn - The Science Monopoly
Nathan Cherny - Overtreatment of cancer patients at the end of life
Gary Schwitzer - 16 Years of Healthcare News Dissected
Independent Journalists and Healthcare Reporting: Overcoming the Challenges
James Tabery - “Personalized Medicine” Wasn’t Personal; “Precision Medicine” Isn’t Precise
Nick Woolley - The trillion-pound cost of preventable cancers in the UK
The Challenges of Screening for Cancer: The Use of Surrogate Endpoints
Ariadna Tibau Martorell - Timely Access in Cancer Care
Is the FDA failing the public?
Jonathan Kimmelman - Do Cancer Patients Benefit by Participating in Clinical Trials?
Understanding the economic & regulatory challenges of cancer prevention
Deborah Cohen - Exposing the Realities of Clinical Trial Research
Drugs for Alzheimer’s: Does Oncology Discovery Provide the Template?
Dr. Nancy Olivieri - Whistleblowing in Medical Research
METRICS International Forum - What’s wrong with clinical trial registries?
Cancer and Alzheimer’s - can we prophesize the future of progress?
Do we need Phase 3 trials in oncology?
Prof. Frank Harrell - Rare degenerative diseases and statistics
Carl Elliott - Medical Experimentation and the Price of Saying No
Egality Health - Unlocking Diversity & Inclusion in Life Sciences
Dr. Andrew Reynolds - Drug development for Cancer Prevention
Taking on Big Pharma: Dr Charles Bennett's Battle